MST1/Hippo Promoter Gene Methylation Predicts Poor Survival in Patients With Malignant Pleural Mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 Trial

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0379-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MiR-Score: A Novel 6-microRNA Signature That Predicts Survival Outcomes in Patients With Malignant Pleural Mesothelioma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2014English

Prognostic Factors in Patients With Malignant Pleural Mesothelioma

International Journal of Biomedicine
2015English

Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Gallium-67 Scanning in Patients With Malignant Pleural Mesothelioma.

Japanese Journal of Medicine
1990English

Heterogeneity in Malignant Pleural Mesothelioma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

A Study of GATA-3 in Malignant Pleural Mesothelioma

Pathology
Forensic MedicinePathology
2020English

Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients With Epithelioid Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Soluble Mesothelin-Related Protein in Pleural Effusion From Patients With Malignant Pleural Mesothelioma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Aberrant DNA Methylation Profile in Pleural Fluid for Differential Diagnosis of Malignant Pleural Mesothelioma

Cancer Science
Cancer ResearchMedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy